Inactive Instrument
Quotes DiaMedica Inc. Toronto S.E.
Stocks
DMA
CA25253T1075
Biotechnology & Medical Research
|
End-of-day quote
Toronto S.E.
|
||
| - CAD | - |
|
| 08-11 | DiaMedica Therapeutics Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-10 | DiaMedica Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Basic data
Market Cap (CAD)
490,873,055
Market Cap (USD)
355,370,343
Net sales (CAD)
0
Net sales (USD)
0
Free-Float
56.63 %
Free-Float capitalization (CAD)
277,968,073
Free-Float capitalization (USD)
201,236,569
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 355M | |
| -0.94% | -0.71% | +45.60% | +103.25% | 68.52B | |
| -0.99% | -6.07% | +30.68% | +74.29% | 62.88B | |
| -1.31% | +0.77% | -12.52% | +381.74% | 28.13B | |
| -2.74% | -3.53% | +26.13% | +13.50% | 25.56B | |
| -1.82% | -6.08% | -4.34% | -18.08% | 24.65B | |
| -2.39% | -5.10% | +17.86% | -19.56% | 19.81B | |
| -1.86% | +1.15% | +205.44% | +353.89% | 17.69B | |
| -1.37% | -3.77% | -9.38% | +528.34% | 14.66B | |
| -0.55% | -1.73% | +54.14% | +164.26% | 14.45B | |
| Average | -1.54% | -1.50% | +39.29% | +175.74% | 27.67B | |
| Weighted average by Cap. | -1.39% | -1.79% | +35.81% | +138.87% |
Historical Quotes: DiaMedica Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- DMAC Stock
- DMA Stock
- Quotes DiaMedica Inc.
Select your edition
All financial news and data tailored to specific country editions
